National Pharmaceutical Congress (NPC) Podcast

By: Chronicle Companies
  • Summary

  • Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry.

    healthbiz.substack.com
    Chronicle Information Resources Ltd.
    Show More Show Less
Episodes
  • S13 E05 AI and the Importance of Data to Pharma Marketers
    Dec 11 2024

    Tom Slowe, CEO of Breadcrumb Analytics, gives insights into using AI to sort and sift through statistics, the importance of context with data, and why AI should only be supplementary to human work.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    Show More Show Less
    30 mins
  • S13 E04 Eli Lilly’s Focus on Innovative Therapeutics
    Nov 20 2024

    Kenneth Custer, President and General Manager of Eli Lilly Canada, gives insights into his background in neuroscience, innovation in healthcare, and progress in therapeutics for obesity and Alzheimer’s.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    Show More Show Less
    24 mins
  • S13 E03 Innovating Rare Disease Research
    Oct 30 2024

    Jonathan Soong, General Manager of Amicus Therapeutics, gives insights into being at the forefront of rare disease innovations, patient support programs, and the importance of real world evidence for rare diseases.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    Show More Show Less
    25 mins

What listeners say about National Pharmaceutical Congress (NPC) Podcast

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.